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 ABSTRACT OF THESIS 
 
 
 
 
CARDIO-RESPIRATORY INFLUENCE ON DYNAMIC CEREBRAL AUTOREGULATION 
DURING HEAD UP TILT MEDIATED PRESYNCOPE 
 
 
Altered cerebral hemodynamics contributes to mechanisms of unexplained syncope. We 
compared dynamic interaction between respiration and cerebral autoregulation in two groups of 
subjects from 28 healthy adults. Based on development of tilt-induced presyncope, subjects were 
classified as Non-Presyncopals (n=23) and Presyncopals (n=5). Airflow, CO2, Doppler cerebral 
blood flow velocity (CBF), ECG and blood pressure (BP) were recorded. To determine whether 
influences of mean BP (MBP) and systolic BP (SBP) on CBF were altered in Presyncopals, the 
coherencies and transfer functions between these variables and mean and peak CBF (CBFm and 
CBFp) were estimated. To determine influence of end-tidal CO2 (ETCO2) on CBF, relative CO2 
reactivity was calculated. The two primary findings were, during tilt in Presyncopals: (1) In 
respiratory frequency region, coherence between SBP and CBFp (p=0.02) and transfer function 
gain between BP and CBFm was higher (MBP, p=0.01, and SBP, p=0.01) than in Non-
Presyncopals. (2) In the last 3 minutes prior to presyncope, Presyncopals had a reduced relative 
CO2 reactivity (p=0.005). Thus the relationship of CBF with systemic BP was more pronounced 
or cerebral autoregulation was less effective preceding presyncope. This decreased 
autoregulation, secondary to decreased ETCO2, may contribute in the cascade of events leading 
to unexplained syncope. 
 
KEYWORDS: Cerebral hemodynamics, Cerebral Autoregulation, Coherence,  
Transfer function, Relative CO2 reactivity. 
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Chapter One: Background 
 
 
Syncope: 
 
Syncope is defined as the temporary loss of consciousness primarily due to a sudden fall in blood 
pressure and a decline in blood flow to the brain. Syncope may be caused by an irregular cardiac 
rate or rhythm, or by changes in blood volume or distribution. Although several heart, 
neurologic, psychiatric, metabolic and lung disorders manifest themselves as syncope, it can also 
occur in otherwise healthy people. Syncope also accounts for 3% of all emergency room visits 
and 6% of all hospital visits (1).  
 
Presyncope i.e., symptoms that often precede syncope, consists of unsteadiness, weakness, or 
cognitive symptoms without loss of consciousness. Presyncope is often a symptom of orthostatic 
hypotension. It may be caused by emotional stress, pain, pooling of blood in the legs, due to 
sudden changes in body position, overheating, dehydration, heavy sweating or exhaustion. 
 
Syncope can be classified into two major types as: 
(i) Cardiogenic syncope.  
This is the most dangerous type of syncope and is caused primarily by an abnormal heart rhythm 
(arrhythmia) or by structural damage to the heart.  
(ii) Non-Cardiogenic syncope. 
There are a variety of non-cardiovascular causes of syncope. These types of syncope often are 
related to problems with the autonomous nervous system (ANS), which controls automatic 
bodily functions such as heart rate and blood pressure. They may occur in otherwise healthy 
people with normal heart function. Neurally mediated syncope is one form of Non-Cardiogenic 
syncope. 
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Neurally mediated syncope (NMS): 
 
Neurally mediated syncope is the most frequently encountered form of Non-Cardiogenic 
syncope. NMS is also referred to as neurocardiogenic, vasovagal, vasodepressor or reflex 
mediated syncope. It is a benign cause of fainting. Neurally mediated syncope is more common 
in children and young adults (1). NMS most often occurs when blood pressure drops, reducing 
circulation to the brain and causing loss of consciousness. Typical NMS occurs while standing 
and is often preceded by a sensation of warmth, nausea, lightheadedness and visual gray out. 
 
Pathophysiology: 
 
Brain parenchyma depends on adequate blood flow to provide a constant supply of oxygen. 
Brain tissue cannot store energy in the form of high-energy phosphates found elsewhere in the 
body; therefore, a cessation of cerebral perfusion results in NMS. Cerebral perfusion is 
maintained relatively constant by a complex feedback system involving cardiac output, systemic 
vascular resistance, arterial pressure, cerebrovascular resistance with intrinsic autoregulation, and 
metabolic regulation. A clinically significant defect in any one of these systems may cause NMS.  
 
Any of the following may precipitate NMS. Cardiac output can be diminished secondary to 
mechanical outflow obstruction, pump failure, hemodynamically significant arrhythmias, or 
conduction defects. More commonly, systemic vascular resistance can drop secondary to 
vasomotor instability, autonomic failure, or vasodepressor/vasovagal response. Arterial pressure 
decreases with all causes of hypovolemia.  
 
Cerebral blood flow (CBF): 
 
The brain is only able to withstand very short periods of ischaemia, unlike the kidney, liver or 
muscle (14). Thus cerebral blood flow must be maintained to ensure a constant delivery of 
oxygen and glucose as well as the removal of metabolic products. Maintenance of cerebral blood 
flow depends on a balance between the pressure within the skull, i.e., intracranial pressure (ICP) 
and the arterial pressure of the blood (mean arterial pressure (MAP)). Cerebral perfusion 
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pressure (CPP) is defined as the difference between mean arterial and intracranial pressures. 
Mean arterial pressure is calculated as diastolic pressure plus one third of the pulse pressure 
(difference between the systolic and diastolic pressures). When blood pressure falls, 
physiological mechanisms attempt to maintain cerebral flow to prevent ischaemia. This process 
is autoregulation. Similarly, when blood pressure rises, the same mechanism (autoregulation) 
stops the blood flow from increasing to excessive levels.  
 
Normal cerebral perfusion pressure is 80 mmHg, but when reduced to less than 50 mmHg there 
is metabolic evidence of ischaemia. If blood flow to the brain is reduced below a critical point 
there is a fall in venous saturation of oxygen. As the flow of blood and delivery of oxygen is 
reduced, the brain, in order to maintain its oxygen supply, extracts more oxygen from the blood, 
leading to a fall in venous oxygen saturation. 
 
The normal cerebral blood flow is 45-50ml 100g-1 min-1, ranging from 20ml 100g-1 min-1 in 
white matter to 70ml 100g-1 min-1 in grey matter (26). There are two essential facts to understand 
about cerebral blood flow. First, in normal circumstances when the flow falls to less than 18-
20ml 100g-1 min-1, physiological electrical function of the cell begins to fail. Second ly, an 
increase or decrease in CBF will cause an increase or decrease in cerebral arterial blood volume 
because of arterial dilatation or constriction.  
 
Autoregulation of CBF 
 
CBF is maintained at a constant level in normal brain inspite of the usual fluctuations in blood 
pressure by the process of autoregulation. It is a poorly understood local vascular mechanism. 
Normally, autoregulation maintains a constant blood flow between mean blood pressure (MBP) 
60 mmHg and 160 mmHg. However in traumatized or ischaemic brain or following 
administration of vasodilator agents, CBF may become blood pressure dependent. Thus as 
arterial pressure rises, so does CBF causing an increase in cerebral volume. Similarly as pressure 
falls, CBF will also fall, reducing ICP, but also inducing an uncontrolled reduction in CBF. In 
this situation if CPP falls below the critical value of 70 mmHg, the patient will have inadequate 
cerebral perfusion (26). Autoregulation will cause cerebral vasodilatation leading to a rise in 
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brain volume. This in turn will lead to a further rise in ICP and induce the vicious circle 
described by the vasodilatation cascade, which results in cerebral ischaemia. This process can 
only be broken by increasing the blood pressure to raise CPP, inducing the vasoconstriction 
cascade. This explains why the maintenance of arterial blood pressure at adequate level by 
careful monitoring and rapid correction if it falls is so important.  
 
Carbon dioxide causes cerebral vasodilation. As the arterial tension of CO2 (PaCO2) rises, CBF 
increases and when it is reduced vasoconstriction is induced. Thus hyperventilation can lead to a 
mean reduction in intracranial pressure of about 50% within 2-30 minutes (18). When PaCO2 is 
less than 25 mmHg there is no further reduction in CBF. Therefore inducing further hypocapnia 
(deficiency of CO2 in the blood) will only shift the oxygen dissociation curve further to the left, 
making oxygen less available to the tissues (26). 
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Chapter Two: Introduction 
 
 
Reflex autonomic mechanisms adjust hemodynamic and respiratory parameters in response to 
orthostasis, i.e. in response to change in posture from supine to an upright position. Altered 
cerebral hemodynamics preceding the development of syncope (temporary loss of 
consciousness), is thought to be one of the primary contributors of syncope (17, 25, 31). 
 
Cerebral blood flow (CBF) is dynamically regulated, primarily in response to changes in 
perfusion pressure and metabolic activity of the brain. Other factors that influence CBF are 
humoral factors and autonomic neural activity (4). In studies exploring orthostatically mediated 
syncope, MBP is often used as a surrogate for perfusion pressure at the brain level (30, 31). As 
defined earlier, cerebral autoregulation (CA) is a characteristic feature of cerebral circulation and 
is the ability of CBF to remain almost constant despite oscillations in MBP. This autoregulation 
is interrupted if mean blood pressure (MBP) values are outside the range of about 60 to 160 
mmHg (5, 17, 25, 31). A sudden decline in blood pressure (BP) is a characteristic observation in 
subjects developing NMS. CA is very sensitive to changes in tissue perfusion pressure and thus 
CA responds within several seconds to changes in BP and would effectively dampen out 
variation in CBF due to changes in BP in the low frequency range (long time periods). In the 
relatively high frequency range (short time periods), CA is less effective. Since the effectiveness 
of CA varies with the frequency range in which the BP oscillations are present, CA is believed to 
be a frequency dependent phenomenon (30). 
 
The chemoregulatory mechanism (CO2 reactivity, i.e., changes in CBF due to changes in end 
tidal CO2) also plays an important role in the determination of CBF even when BP is inside the 
autoregulatory range. In subjects who are orthostatically intolerant, i.e. those who often develop 
either syncope or presyncope (symptoms that precede syncope), during orthostasis, it is 
hypothesized that hypocapnia may contribute to a reduction in CBF and thus contribute to 
orthostatic intolerance (12, 13). Consistent with this hypothesis, several studies indicate that CO2 
breathing might increase orthostatic tolerance (2, 16).  Results of a recent study by Serrador et al 
(22) suggest that just before onset of symptoms of presyncope, there was a stronger correlation 
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(in Presyncopal subjects than in Non-Presyncopal subjects) between end tidal CO2 (ETCO2) and 
CBF and this study attributes the stronger correlation to the hypocapnia observed in the subjects 
with presyncopal symptoms. Taken together, the above results indicate that the influence of 
ETCO2 on CBF may also contribute to the phenomenon of orthostatically mediated syncope. 
Some recent data suggest that the CO2 reactivity is less in the hypocapnic range than in the 
hypercapnic range (11).  
 
In the upright position, reduced mean arterial pressure and cardiac output challenge cerebral 
autoregulation (25). Small but significant decreases in end-tidal and arterial partial pressures of 
carbon dioxide are also observed in the upright position (21, 29). Whether this link between 
ETCO2 and CBF is causal and necessary, or just facilitates the onset of presyncope is unclear. 
Our objective in the present study was to determine if cardio-respiratory interactions contribute 
to the phenomenon of unexplained syncope. We were particularly interested in how changes in 
MBP and ETCO2 influence CBF prior to the onset of presyncope. 
 
To investigate the cardio-respiratory influence, we estimated coherence and transfer function 
between cardiovascular, cerebral and respiratory parameters. In order to investigate the influence 
of BP on CBF, we estimated coherencies and transfer functions between BP (both MBP and 
SBP) and CBF. To determine the influence of ETCO2 on CBF, we computed relative CO2 
reactivity (percent change in mean CBF per mmHg change in ETCO2). Coherence estimates, 
Transfer function estimates and relative CO2 reactivity were estimated for a group of subjects 
who did not develop any symptoms during 700 passive head up tilt (HUT), referred to as Non-
Presyncopal group and a group of subjects who developed presyncopal symptoms during HUT, 
i.e. the Presyncopal group.  
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Chapter Three: Methods  
 
 
Twenty-nine healthy adults (age: mean=29 years, range 21-41; 15 males, 14 females) 
participated in our study. The study was approved by the Institutional Review Board at the 
University of Kentucky. All subjects gave written informed consent. The subjects were screened 
to exclude smokers, pregnant women, those with a history of cardiovascular or respiratory 
disease and those taking prescription medication that may have affected their ventilatory 
sensitivity to CO2 or cardiovascular function. 
 
During the study, the subjects breathed through a mouthpiece connected to a pneumotachograph 
(Fleish) and a non-rebreathing valve. A rubber nose clip was used to ensure that the subjects 
breathed through the mouthpiece. An infrared CO2 monitor (Novametrix) was used for 
measuring CO2 fraction (in mmHg) in inspired and expired gas. Lead II electrocardiogram was 
recorded. Beat by beat BP was measured continuously using a non-invasive finger blood 
pressure monitor (Finapres). A sling was used to hold the hand with the finger cuff at the level of 
the heart during HUT. Cuff arterial pressure was measured in the right arm by using a Dinamap 
arterial pressure monitor. The cuff arterial pressure was taken every 3 minutes in order to 
calibrate absolute levels of BP values obtained from the Finapres. CBF was measured using a 
Transcranial Doppler (500M TCD, 2 MHz, Multigon Inc).  
 
Measurement of CBF: 
 
A 2-MHz Transcranial Doppler (TCD) is a non- invasive ultrasound technology used to assess 
blood flow velocity in the right middle cerebral artery (MCA). The TCD provides blood flow 
velocity on a real time, beat to beat basis. The MCA was identified by an insonation pathway 
through the right temporal window, just above the zygomatic arch. Optimization of the Doppler 
signals from the MCA was done by varying the amplitude volume depth in incremental steps and 
at each depth varying the angle of insonance to obtain the best quality signals. We defined 
optimal velocity measurements as those in which a clearly defined Doppler waveform and 
envelope were present. When necessary and to maintain a clearly defined waveform and 
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envelope, the gain settings were carefully adjusted in a limited fashion, therefore ensuring that 
only optimal velocity data were recorded. A head band was used to hold the probe, ensuring the 
optimal insonation position and angle for the duration of the experiment. Markings of the 
Doppler probe’s position were made, allowing easy relocation of the probe if movement 
occurred when the subject was tilted. 
 
Thus, seven channels of data were collected using a WINDAQ data acquisition system (DATAQ 
instruments, Akron, Ohio), namely  
(1) Airflow 
(2) CO2 
(3) ECG 
(4) BP 
(5) CBF 
(6) Pseudo-random binary sequence (PRBS) 
(7) Tilt angle 
 
To elicit an orthostatic response, subjects were passively tilted to a 700 head up position. The 
experimental protocol included four sections. In the first section, subjects were asked to lie 
supine on the tilt table and breathe room air for 10 minutes (Supine Control). For the next 10 
minutes, the subjects remained in the supine position and the inspired gas for each breath 
consisted of either room air or 5% CO2 in room air according to a pseudo-random binary 
sequence (PRBS) (Supine PRBS).  Solenoid valves under computer control were used to switch 
between the two. A computer program was used to switch the solenoid valves during expiration 
according to a PRBS. During breathing to the PRBS, when the number in sequence was 0, the 
subjects breathed room air, when the number was 1, the subjects breathed room air plus 5% CO2.   
The PRBS was generated such that on average, in the given study window, subjects breathed 
equal number of breaths that were room air plus CO2 and equal number that were room air only. 
Therefore, the subjects breathed on an average 2.5% CO2 during the PRBS section. At the end of 
Supine PRBS, the table was tilted to a 700 head-up position. Once in the tilt position, we again 
switched the inspired gases between room air an The PRBS sections were used to broaden input 
(end tidal CO2, which is an analog of arterial partial pressure of CO2) spectra in order to better 
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estimate ventilatory chemo sensitivity to determine role of the chemoreflex in the mechanisms of 
unexplained syncope.  After Tilt PRBS (average 2.5% CO2), the 700 d air plus 5% CO2 for an 
additional 10 minutes (Tilt PRBS). tilt was continued for another 20 minutes during which 
subjects breathed room air only (Tilt Control). At the end of 30 minutes, the tilt table was 
brought back to the horizontal position. The experimental protocol is shown schematically in 
Figure 1. The total tilt duration was 30 minutes or less than 30 minutes if the subject developed 
presyncopal symptoms. If a subject developed presyncopal symptoms, the tilt table was 
immediately returned to the supine position. These studies were conducted as a part of a broader 
effort to investigate the role of cardio-respiratory interaction in the development of 
orthostatically mediated syncope. For this thesis, primarily, data from Tilt Control segment was 
used to explore how changes in MBP and ETCO2 influence CBF prior to the onset of 
presyncope. Results from other segments of the study are reported elsewhere (27). 
 
Among the twenty nine subjects, six subjects developed presyncopal symptoms during Tilt 
Control. One presyncopal subject developed symptoms early in Tilt Control (2 minutes). As we 
did not have adequate length of data collected from this subject to compute transfer functions 
and coherencies, data from this subject were not included in further analyses and all subsequent 
results are presented from 28 subjects. Based on the development of Presyncopal symptoms, the 
subjects were classified into two groups as Presyncopals (5 subjects) and Non-Presyncopals (23 
subjects). 
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Figure 1. Schematic of the experimental protocol. The figure shows the four sections of the 
study. Supine Control; Supine PRBS; Tilt PRBS and Tilt Control. 
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Chapter Four: Analysis 
 
 
All data were digitized at the rate of 500 samples per second. Preprocessing of data was done 
using MATLAB programs. From the ECG signal, a program was used to identify the location of 
peaks of the R wave in the ECG (Figure 2). From these R wave peak locations, beat by beat R-R 
intervals (in msec) were computed. From the calibrated BP trace, between the two R waves, the 
maximum, the mean and the minimum value of BP were computed. These maximum, mean and 
minimum values of BP resulted in beat by beat sys tolic blood pressure (SBP), mean blood 
pressure (MBP) and diastolic blood pressure (DBP). From the calibrated CBF trace between the 
two R waves, the maximum (or peak) and the mean value of CBF were computed. The 
maximum and mean values of CBF were referred to as the beat by beat CBFp and CBFm. 
 
In order to study cardio-respiratory interaction, we synchronized cardiac variables with 
respiratory variables. In order to do so, we had to estimate these variables on the same time scale. 
The procedure to obtain both the cardiac and the respiratory variables on the same time scale is 
as follows. From the R-R intervals, beat by beat SBP, beat by beat MBP, beat by beat CBFm and 
beat by beat CBFp, we constructed a new time series in which it was assumed that for the time 
interval between successive R waves, the R-R intervals, and beat by beat values of SBP, MBP, 
CBFm and CBFp remained constant. With this assumption, a new time series was created with the 
same sampling rate (samples/second) as the original signal.  An example of the new time series 
created for the R-R intervals is shown in Figure 3. An example of the new time series created for 
the SBP, MBP and DBP is shown in Figure 4. An example of the new time series created for the 
CBFm and CBFp is shown in Figure 5. We then low pass filtered all the new time series signals at 
20 Hz and sub-sampled the data at 5 samples/second for further processing. 
 
For the respiratory signals, we performed a similar operation. Before the start of each 
experiment, a flow signal using the 500 ml syringe was recorded and was used to calibrate the 
flow signal recorded from the subject. After the flow signal was calibrated the zero-crossings 
(data points where the flow signal crossed zero flow) were identified as in Figure 6. Flow was 
integrated and volume was obtained. If small drifts in the baseline were present in the zero 
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volume value, adjustments were made by fitting straight lines to the minimums of volumes (if 
they are different from 0) and subtracting the fitted lines from the signal.  Thus we obtained a 
volume signal (i.e., changes in lung volume), which varied from 0 to a maximum (tidal volume 
for that breath) and back to 0 (Figure 7). We used the maximum volume (tidal volume (ml)) for 
each breath and assumed that the volume would remain constant between two successive breaths. 
Similarly breath duration (msec) and ventilation (ml/sec) were calculated and these values were 
also held constant for the time interval between two successive breaths. Thus, we created a new 
time series with tidal volume, breath duration and ventilation, similar to the cardiac variables and 
then sub-sampled it in order to synchronize with cardiac variables. Figure 8 shows the Tidal 
Volume and Ventilation from one subject on a breath by breath basis. 
 
The CO2 signal was also calibrated for each subject.  Before the start of the experiment a cannula 
was inserted into a small bag containing a pre-mixed gas of known CO2 concentration (5% CO2 
+ 21% O2 balance N2). This signal served as a reference to calibrate the CO2 signal. A CO2 
sampling tube was connected to a transducer that sensed the CO2 expired and inspired by the 
subjects. The use of the sampling tube resulted in a delay in the CO2 signal. We shifted the CO2 
back to account for the delay, which was experimentally determined to be about 800 msec. After 
the delay was taken into account, the maximum (end tidal) and minimum (inspired) CO2 values 
were obtained for each breath. End tidal CO2 (ETCO2) and Inspired CO2 (INCO2) values were 
also obtained on a breath by breath basis (between the zero-crossings of the volume signal) 
(Figure 9). For each breath the minimum (INCO2) and maximum (ETCO2) were calculated.  As 
before, the inspired and end tidal CO2 was assumed to remain constant between two breaths and 
new time series were created. We calculated the following on a breath by breath basis for mean 
value estimation: tidal volume (Vt), breath duration (Tb), minute ventilation (VE), ETCO2 and 
INCO2. After the above preprocessing, we obtained all the cardio-respiratory variables on a 
synchronous time scale. After this pre-processing, we conducted coherence and transfer function 
analysis. 
 
A correction factor of 15 mm Hg was applied to BP measurements in supine position to account 
for placement of hand over the thorax (to account for the distance from the thorax surface to the 
approximate location of the heart). The average of the estimated distance between the location of 
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the finger cuff and heart level measured from 16 subjects was used to calculate this hydrostatic 
correction.  
 
Coherence and Transfer function estimates between BP (MBP and SBP) and CBF (CBFm and 
CBFp) were estimated to compare dynamic CA between Presyncopals and Non-Presyncopals.  
The BP, CBF and ETCO2 decrease prior to the onset of presyncope and this can be seen from 
one Presyncopal subject’s data in Figure 10. 
 
Additionally, Coherence was also estimated between  
(i) Respiratory variables such as INCO2, ETCO2 with cardiovascular variables like BP (SBP and 
MBP), CBF (CBFp and CBFm).  
(ii)  Vt ,VE  with SBP, RR-interval, INCO2, ETCO2. 
(iii) RR-interval with SBP, CBFp, CBFm. 
Among these combinations only the following functions had a coherence estimate significantly 
greater than zero (the zero coherence bound was estimated using the Fisher’s distribution (3)):  
(1) RR-interval and SBP 
(2) RR-interval and CBF (CBFp and CBFm) 
(3) ETCO2 and Vt, VE 
Transfer functions were estimated only for these combinations that had a coherence estimate 
significantly greater than zero. 
 
Transfer function relation H(f) between input signal x(t) and output signal y(t) was calculated as 
(3) 
H(f) = Sxy(f) / Sxx(f) 
Where Sxx(f) is the autospectrum of the input signal (BP) and Sxy(f) is the cross spectrum 
between the input and the output signals (CBF).  
 
Coherence relation C(f ) between two signals was calculated as (3)  
C(f) = | Sxy(f) |2 / [ Sxx(f) Syy(f) ] 
Where Syy(f) is the autospectrum of the output signal (CBF).  
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For the transfer function estimation, we used 100 second data segments with 50% overlap. After 
removal of the mean from each segment, a Hamming window was used for spectral 
smoothening. The estimated transfer functions and coherencies were integrated within three 
frequency regions of interest, namely (1) the low frequency (LF) region, defined as < 0.05 Hz, 
(2) the mid frequency (MF) region, defined as 0.05 Hz to (Abf –Abf*0.2) Hz, where Abf was the 
average breathing frequency of the individual subject during the Tilt Control section of the study 
and (3) the respiratory or high frequency (HF) region, defined as (Abf –Abf*0.2) Hz to 0.5 Hz. 
 
Our aim was to study cardio-respiratory interaction and hence we focused on differences 
between the groups during Tilt Control and Supine Control in the respiratory frequency region, 
i.e. the HF region, although we did integrate transfer functions and coherencies within the sub-
respiratory frequency regions as well (i.e. the so called very low and low frequency regions 
(30)).  
  
All subjects who developed presyncopal symptoms did so during the Tilt Control segment of the 
study. Comparisons between the two groups (Non-Presyncopal and Presyncopal) were made 
during all four segments of the study. The average duration from the onset of Tilt Control to 
when the subjects developed presyncope was 13 minutes (range: 8 to 20 minutes). In order to 
maintain consistent variance in these auto and cross spectral estimates, which can be influenced 
by data record length, data during the last 13 minutes of Tilt Control were used to compute these 
estimates from Non-Presyncopal subjects.  
 
We calculated mean value of CBFm during early part of Tilt Control (3 minutes) and also during 
the last 3 minutes of Tilt Control. From the above two values, the percent were estimated for 
changes in CBFm (with respect to early Tilt Control value). For the same two 3 minute windows, 
corresponding mean was calculated for ETCO2 values and the difference were estimated between 
the two ETCO2 values (change in ETCO2). The ratio between the percent change in CBFm and 
the change in ETCO2 was termed Relative CO2 reactivity. Relative CO2 reactivity was calculated 
for the last 3 minutes leading to presyncope. Similar to the approach used by Markwalder et al 
(15) in their study, relative CO2 reactivity was calculated as percent change in CBFm per mmHg 
change in ETCO2. 
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All analyses were performed using MATLAB. Differences between the groups were tested for 
statistical significance using a t-test with unequal variance. Within a group, differences between 
the protocol segments were tested for statistical significance using a single factor ANOVA. 
Significance was accepted at a level of p < 0.05. 
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Figure 2. An example of ECG trace with R wave peak detection. 
 
Figure 3. An example of ECG wave with the R-R interval value held constant between 
consecutive R waves. The red trace shows the new R-R interval time series (ECG trace was 
rescaled). 
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Figure 4. An example of calibrated BP signal with new time series for SBP in red, new time 
series for MBP in cyan and new time series for DBP in green. 
 
Figure 5. An example of calibrated CBF signal with new time series for CBFp in red and new 
time series for CBFm in green. 
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Figure 6. An example of calibrated airflow signal with the zero-zero crossings marked. 
 
Figure 7. An example of instantaneous lung volume computed from airflow in a subject. 
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Figure 8. The top panel is an example of the  breath by breath Tidal volume and the bottom panel 
is the breath by breath Ventilation for the study (collected from one Non-Presyncopal). 
 
Figure 9. An example of CO2 trace calibrated to CO2%, with ETCO2 and INCO2 for each breath 
marked in red and green. 
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Figure 10. An example of MBP (top), ETCO2 (middle) and CBFm (bottom) shows a monotonic 
decrease in these variables prior to presyncopal symptoms (marked by the red line). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  21
Chapter Five: Results 
 
 
In the Non-Presyncopal group, mean heart rate and MBP increased during Tilt PRBS and Tilt 
Control compared with Supine Control (Table 1). VE and Vt were tending to be higher during 
Tilt Control compared with Supine Control, but the differences were not significant (for VE 
p=0.13, F=0.38 and for Vt p=0.53, F=2.32). During Tilt Control, ETCO2 decreased compared to 
both Supine Control and Tilt PRBS, and as expected, ETCO2 increased during Supine PRBS. 
There was no increase in ETCO2 during Tilt PRBS compared to Supine Control with the increase 
due to inspired CO2 likely being offset by a decrease in mean ETCO2 in response to postural 
changes. In the Presyncopal group, changes in these variables were generally in the same 
direction as for the Non-Presyncopal group (Table 2). The lack of significance in some variables 
was probably a consequence of the limited number of subjects in the Presyncopal group. 
Comparison between the two groups showed that during Tilt Control, Non-presyncopals had a 
significantly (p<0.05) higher MBP and SBP than Presyncopals, while Presyncopals had a 
significantly higher Tidal Volume (Vt) (p< 0.05, Table 1 and Table 2).  
 
Coherence and Transfer function estimates between BP (MBP and SBP) and CBF (CBFp and 
CBFm) were estimated for LF, MF and HF for comparison between the two groups. For example, 
coherence between MBP and CBFm was estimated as the ratio between, the squared magnitude 
of the cross spectrum of MBP and CBFm (Figure 13) and the product of the autospectrum of 
MBP (Figure 11) with the autospectrum of CBFm (Figure 12). The coherence estimate between 
MBP and CBFm from one Non-Presyncopal subject is shown in Figure 14. Transfer function 
between MBP and CBFm was estimated as the ratio between, the cross spectrum of MBP and 
CBFm (Figure 13) and the autospectrum of MBP (Figure 11). The transfer function gain between 
MBP and CBFm from one Non-Presyncopal subject is shown in Figure 15. Coherence and 
transfer function estimates were calculated during Supine Control and Tilt Control segments of 
the protocol. Differences between the groups became evident during the Tilt Control segment.  
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Coherence estimates between BP (MBP and SBP) and CBF (CBFm and CBFp) during Tilt 
Control: 
Average coherence functions estimated between MBP and CBFm for Tilt Control are shown in 
Figure 16 (a).  Consistent with other studies (19, 30, 31), we assumed that a linear relation exists 
between input (BP) and output (CBF). In the high frequency region, integrated coherence 
between MBP and CBFm tended to be higher in the Presyncopal group, although the difference 
did not meet our threshold of significance (p=0.09, F=2.01 Figure 20(a)).   
 
Figure 18 (a) shows the coherence functions estimated between SBP and CBFm in Tilt Control. 
In the high frequency region, Presyncopals tended to have a higher integrated coherence (p=0.07, 
F=2.01) between SBP and CBFm than Non-Presyncopals (Figure 20 (c)). Coherencies estimated 
between MBP and CBFp, and between SBP and CBFp, are shown in Figure 17(a, b). Integrated 
coherencies between BP (both MBP and SBP) and CBFp in the high frequency region were 
higher in the Presyncopal group, the difference for SBP was significant (p=0.02) (Figure 20 (d)) 
while that for MBP was not (p=0.07, F=2.01) (Figure 20(b)). 
 
Transfer function estimates between BP (MBP and SBP) and CBF (CBFm and CBFp) during Tilt 
Control: 
In the high frequency region, the transfer function gain between MBP and CBFm was larger in 
the Presyncopal subjects (p=0.01, Figure 16 (b) and Figure 21(a)). Similarly, transfer function 
gain between SBP and CBFm in the high frequency region was larger in Presyncopal group 
(p=0.01) than in the Non-Presyncopal group (Figure 18 (b) and Figure 21(b)). Transfer function 
gain between BP (both MBP and SBP) and CBFm, in the LF region was also significantly higher 
in the Presyncopal group (for MBP, p=0.03, Figure 16 (b); for SBP, p=0.03, Figure 18 (b)).  
 
Coherences and transfer function gains estimated between  
(1) RR-interval and SBP 
(2) RR-interval and CBF (CBFp and CBFm) 
(3) ETCO2 and Vt, VE 
were not significantly different in the LF, MF and HF regions, during Supine Control and Tilt 
Control  segments of the study.  
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Relative CO2 reactivity calculated for the last 3 minutes prior to the end of HUT showed a 
decreased reactivity in Presyncopal subjects when compared with Non-Presyncopals (p=0.005, 
Figure 19).  As stated in the analysis section, Relative CO2 reactivity was calculated as the ratio 
of the percent change in CBFm per mmHg change in ETCO2 (15).  The Presyncopals exhibited a 
higher percent decrease in CBFm (4.6%) than Non-Presyncopals (3.3%) during the three minutes 
preceding presyncope compared to early Tilt Control, although this decrease was not significant. 
Both groups decreased ETCO2 significantly from initial Tilt Control to the last 3 minutes of tilt. 
However, the decrease in Presyncopals was larger (from 40.4 to 37.7 mmHg, p=0.009) than that 
in Non-Presyncopals (41.54 to 41.06 mmHg, p=0.05). The decrease in ETCO2 was significantly 
larger in Presyncopals than in Non-Presyncopals (p=0.03). 
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Table 1. Average Cardiovascular and Respiratory variables from 23 Non-Presyncopal subjects 
during the four sections of the study. Data are shown as mean ± standard error of mean.  
Superscripts *, †, and ‡ indicate significant difference (p<0.05) between Supine Control-Supine 
PRBS*, Supine Control-Tilt PRBS†, Supine Control-Tilt Control‡; • indicates significant 
difference between Tilt PRBS and Tilt Control; ?  indicates significant difference between 
Presyncopals and Non-Presyncopals. 
Parameters  
(Mean ±  Std 
error of 
mean) 
 
 
Supine Control 
 
Supine PRBS 
 
Tilt PRBS 
 
Tilt Control 
 
Heart rate 
(Beats/min) 
 
 
74.05 ± 2.51 
 
72.01 ± 2.4 
 
86.87† ± 2.35 
 
91.5‡ ± 2.42 
 
Mean BP 
(mmHg) 
 
 
91.04 ± 2.54 
 
92.56 ± 2.3 
 
103.3† ± 3.63 
 
105.71‡ ± 4.3?  
 
Systolic BP 
(mmHg) 
 
 
123.81 ± 3.79 
 
127.55 ± 3.99 
 
135.36† ± 4.59 
 
132.39 ± 4.55?  
 
CBFm 
(cm/sec) 
 
 
73.41 ± 3.19 
 
74.17 ± 3.28 
 
64.58† ± 2.88 
 
64.4‡ ± 2.45 
 
CBFp 
(cm/sec) 
 
 
86.59 ± 3.91 
 
86.69 ± 3.92 
 
74.28† ± 3.51 
 
73.97‡ ± 3.16 
 
Vt (ml) 
 
 
585.03 ± 40.7 
 
634.17 ± 37.7 
 
727.34† ± 48.55 
 
617.87 ± 33.51 
 
Resp rate 
(Breaths/min) 
 
 
14.26 ± 0.56 
 
13.95 ± 0.59 
 
13.93 ± 0.83 
 
13.87 ± 0.53 
  
VE (L/min) 
 
 
7.62 ± 0.4 
 
8.72 ± 0.48 
 
9.94† ± 0.57 
 
8.51• ± 0.42 
 
ETCO2 
(mmHg) 
 
 
45.37 ± 0.84 
 
47.57* ± 0.76 
 
45.71 ± 0.83 
 
41.47‡• ± 0.89 
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Table 2. Average Cardiovascular and respiratory variables from 5 Presyncopal subjects during 
the four sections of the study. Data are shown as mean ± standard error of mean.  Superscripts †, 
and ‡ indicate significant difference (p<0.05) between Supine Control-Tilt PRBS†, Supine 
Control-Tilt Control‡; ?  indicates significant difference between Presyncopals and Non-
Presyncopals. 
Parameters  
(Mean ± Std 
error of 
mean) 
 
 
Supine Control 
 
Supine PRBS 
 
Tilt PRBS 
 
Tilt Control 
 
Heart rate 
(Beats/min) 
 
 
71.02 ± 4.0 
 
69.27 ± 3.46 
 
92.45† ± 5.58 
 
100.07‡ ± 5.32 
 
Mean BP 
(mmHg) 
 
 
87.92 ± 2.59 
 
89.59 ± 1.5 
 
92.73 ± 2.13 
 
91.78 ± 1.45 
 
Systolic BP 
(mmHg) 
 
 
122.03 ± 4.54 
 
125.69 ± 3.94 
 
125.06 ± 4.63 
 
118.93 ± 5.17 
 
CBFm 
(cm/sec) 
 
 
81.66 ± 5.95 
 
82.44 ± 5.15 
 
75.42 ± 5.3 
 
70.29 ± 4.44 
 
CBFp 
(cm/sec) 
 
 
96.17 ± 7.22 
 
96.57 ± 6.22 
 
85.86 ± 6.2 
 
80.88 ± 4.99 
 
Vt (ml) 
 
 
686.82 ± 102.5 
 
717.26 ± 87.88 
 
886.42 ± 95.04 
 
824.3 ± 92.51?  
 
Resp rate 
(Breaths/min) 
 
 
12.94 ± 1.15 
 
13.44 ± 0.79 
 
12.98 ± 1.06 
 
10.88 ± 1.6 
  
VE (L/min) 
 
 
8.36 ± 0.76 
 
9.93 ± 1.07 
 
11.77† ± 0.93 
 
10.37 ± 1.03 
 
ETCO2 
(mmHg) 
 
 
45.63 ± 2.83 
 
48.15 ± 2.73 
 
45.34 ± 2.76 
 
39.11 ± 3.08 
 
  
 
 
  26
 
Figure 11. An example of Power Spectral Density of MBP for a Non-Presyncopal subject. 
 
Figure 12. An example of Power Spectral Density of CBFm for a Non-Presyncopal subject. 
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Figure 13. An example of Cross Spectrum between MBP and CBFm for a Non-Presyncopal 
subject. The Y-axis is power in arbitrary units. 
 
Figure 14. An example of coherence between MBP and CBFm computed from a Non-
Presyncopal subject during tilt control.  
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Figure 15. An example of transfer function gain between MBP and CBFm from a Non-
Presyncopal subject during Tilt Control. 
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Figure 16. Average coherencies between MBP and CBFm in Presyncopal subjects (thick line) 
and Non-Presyncopal subjects (thin line) are shown in panel a. The average transfer function 
gain between MBP and CBFm, in panel b, shows that as for coherence, the gain of the transfer 
function was higher over most of the frequency range for Presyncopal subjects (thick line) than 
Non-Presyncopal subjects (thin line). The gain of the transfer function was significantly higher in 
the respiratory frequency region in the Presyncopals (p=0.01). 
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Figure 17. Average coherencies between MBP and CBFp in Presyncopals (thick line) and Non-
Presyncopals (thin line) are shown in panel a. The Presyncopals had a higher coherence over 
most of the frequency range. The average coherencies between SBP and CBFp are shown in 
panel b, and again the Presyncopals had a higher coherence over most of the frequency range. 
This increased coherence between SBP and CBFp was significantly higher in the Presyncopals in 
the respiratory frequency region (p=0.02). 
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Figure 18. Panel a shows the coherence estimate between SBP and CBFm in both Presyncopal 
subjects (thick line) and Non-Presyncopal subjects (thin line). Notice that the Presyncopals 
tended to have higher coherence in the HF region (p=0.07). Panel b shows the transfer function 
gain between the two groups. The Presyncopals show a significant higher gain (p=0.01) in the 
same HF region. 
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Figure 19. The above plot shows the average relative CO2 reactivity (with standard error of mean 
bars) of the Non-Presyncopals (left bar) and the Presyncopals (right bar). The Non-Presyncopals 
had a significantly higher relative CO2 reactivity than the Presyncopals in the last 3 minutes 
preceding presyncope (p=0.005). 
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Figure 20. Panel (a) shows the integrated coherence estimate between MBP and CBFm. Panel (b) 
is the integrated coherence between MBP and CBFp. Panel (c) shows the integrated coherence 
estimate between SBP and CBFm. Panel (d) is the integrated coherence between SBP and CBFp. 
The integrated coherence estimates are for the HF region and bars are the standard error of mean 
for the Presyncopals (right bar) and the Non-Presyncopals (left bar). The Presncopals have 
higher coherence compared to the Non-Presyncopals and this difference is significant for the 
coherence between SBP and CBFp (Panel (d)). 
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Figure 21. The plots show the integrated transfer function gain with standard error of mean bars 
between MBP & CBFm (Panel (a)); SBP and CBFm (Panel (b)) in the HF region between the 
Presyncopals (right bar) and the Non-Presyncopals (left bar). 
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Chapter Six: Discussion 
 
 
The primary findings of our study were that prior to development of symptoms during HUT, in 
Presyncopals the coherence between SBP and CBFp and gains of transfer functions between BP 
(both MBP and SBP) and CBFm were higher in the respiratory frequency region than in Non-
Presyncopals. In the last 3 minutes prior to presyncope, there was a reduced relative CO2 
reactivity in the Presyncopal group compared with Non-Presyncopals. Although the Presyncopal 
group had a larger decrease in CBF, the decreased reactivity was a result of a much larger 
decrease in ETCO2 in these subjects. These findings suggest that in the respiratory frequency 
region, the relationship between BP and cerebral hemodynamics is possibly enhanced, or is 
slightly more pronounced during a time interval preceding the development of HUT-induced 
presyncope. The relative CO2 reactivity decreased preceding presyncope, however the decrease 
in ETCO2 was large enough to initiate a decrease in CBF even though the relationship between 
ETCO2 and CBF was diminished.  
 
As stated before, a characteristic feature of cerebral circulation is CA, i.e. regulation of CBF. The 
myogenic hypothesis of CA suggests that the cerebral smooth muscles constrict or relax in 
response to an increase or decrease in BP (8). In our study, during Tilt Control, prior to 
presyncopal symptoms (13 minutes), subjects in the Presyncopal group exhibited an increased 
coherence between SBP and CBFp in the high frequency region. Assuming that a causal link 
between BP and CBF exists, an assumption supported by previous studies (8), the increased 
coherence indicates a tighter coupling between systemic BP and CBF. Although higher 
coherence does not necessarily indicate linearity, a higher value of coherence does reflect more 
concurrent dynamic changes. Conversely, a low value of coherence (coherence < 0.5) suggests 
either one or a combination of the following factors, (i) non- linear relation between BP and CBF, 
(ii) no relationship between the two or (iii) low signal to noise ratio. We interpret our results, 
therefore, as indicative of a more enhanced or engaged coupling between systemic BP and CBF 
in the group of subjects who developed presyncope compared with those that did not. Such an 
enhancement of the coupling is consistent with the notion that the CA was less active in this 
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group than in the Non-Presyncopal group. Such interpretation is also consistent with the previous 
findings of others (5, 31).  
 
The transfer function between BP (both MBP and SBP) and CBFm showed an increased gain in 
the high frequency region in the Presyncopal group. The increased gain suggests that oscillations 
in CBF, concurrent with those in BP within the respiratory frequency region, are of larger 
magnitude in subjects who develop presyncopal symptoms. The steady state or mean systemic 
BP values were within the autoregulatory range, so we assume that cerebral blood pressure 
values were as well. Our results suggest, therefore, that a larger portion of dynamic changes in 
systemic BP were transferred to CBF in the Presyncopal group than in the Non-Presyncopal 
group. Zhang et al (30) recently showed that the short term regulation of cerebral blood flow in 
response to changes in arterial pressure can be modeled as a transfer function with qualities of a 
high pass filter spanning the frequency range of 0.07 to 0.30 Hz.  This range of the high pass 
filter was determined in their study as a frequency range for which coherence estimate was > 0.5.  
Consistent with these previous studies, we also observed high pass filter like behavior in 
Presyncopal subjects within a range of about 0.07 to 0.3 Hz (Figure 16(a)). Since phase 
calculations from transfer function estimates are more susceptible to signal to noise ratio and also 
because other studies (19, 31) failed to see differences in phase characteristics between 
Presyncopal and Non-Presyncopal subjects, we focused our attention on gain characteristics from 
transfer function estimates. 
 
The metabolic hypothesis of CA, a companion to the myogenic hypothesis, suggests that cerebral 
blood flow responds to metabolites such as CO2, which have vasoactive properties. The 
Presyncopal subjects exhibited a decreased relative CO2 reactivity compared to the Non-
Presyncopals, during the last three minutes leading to presyncope. Relative CO2 reactivity was 
calculated as the ratio of the percent change in CBFm per mmHg change in ETCO2 (15).  As 
stated earlier, the Presyncopals tended to have a higher percent change in CBFm than Non-
Presyncopals during the three minutes preceding presyncope compared to early Tilt Control (the 
differences were not significant, i.e. p>0.05). Although both groups decreased ETCO2 
significantly from initial Tilt Control to the last 3 minutes of tilt, the decrease in ETCO2 was 
significantly higher in the Presyncopals compared with Non-Presyncopals (p=0.03). Thus the 
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higher magnitude of decrease in ETCO2 in the Presyncopal subjects was enough to offset the 
larger decrease in CBFm such that the ratio of the two, i.e. reactivity, was lower. The relative CO2 
reactivity values estimated by us are consistent with those reported by Markwalder et al (15) and 
by Ide et al (11). The decreased reactivity observed, during more pronounced hypocapnia in the 
Presyncopal group, is consistent with previous results (11). It is possible that the decrease in 
ETCO2 in the Presyncopal subjects was large enough to partially offset the decreased reactivity 
such that the decrease in CBF was larger in the Presyncopals than in the Non-Presyncopals.   
 
We recognize that the Doppler measurement that we used measures blood flow velocity, which 
is different from CBF. However, Serrador et al (22) have shown that the middle cerebral artery, 
i.e. the artery that we insonated, does not undergo appreciable change in diameter upon 
orthostasis, suggesting that the blood flow velocity measures are an acceptable surrogate for 
cerebral blood flow. 
 
Carey et al (5) inferred from their study that dynamic CA is preserved in presyncopals initially 
after HUT and deteriorated immediately before syncope. Similarly we did not observe significant 
differences between the groups during Tilt PRBS (10 minutes) indicating that dynamic CA was 
not different between the groups during the initial part of HUT (results not shown). Our results 
suggest that autoregulatory function remains intact in Non-Presyncopal subjects during 
prolonged (i.e. 30 minutes) orthostasis but is compromised early in Presyncopal subjects. The 
compromise in CA function is supported by an increase in coherence and transfer function gain 
between systemic inputs (BP) and cerebral output (CBF). Consistent with this interpretation, 
Carey et al’s results (5) also support the view that though hypotension during presyncope is 
probably precipitated by sympathetic nervous system withdrawal, loss of consciousness during 
syncope may be caused by cerebral hypoperfusion. It is possible, therefore, that impairment of 
CA may contribute to development of early presyncopal symptoms during HUT. Furthermore, 
Carey et al (5)  demonstrated that the impairment of CA was similar in patients and control 
subjects who developed presyncopal symptoms. Therefore, though we recruited ‘non-patient’ 
subjects, the alterations in dynamic CA observed in presyncopal subjects in our study may be 
relevant to the mechanisms of unexplained syncope in patients as well. Altered cerebral 
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hemodynamics and brain oxygenation availability prior to neurogenic syncope was also observed 
by Rodriguez-Nunez et al (17).  
 
Zhang et al 1998 (31), also demonstrated a deterioration of dynamic CA during lower body 
negative pressure (LBNP) and suggested that these changes may contribute to presyncope. There 
are important differences between HUT and LBNP in terms of engagement of proprioceptor and 
vestibular reflexes (6, 20, 24, 28). However, we observed similar deterioration of dynamic CA in 
Presyncopal subjects during orthostatic stress using HUT. In contrast, Schondorf et al (19) 
reported that dynamic CA was preserved in neurally mediated syncope during the 3 minutes 
preceding syncope from a subject pool that included patients and normals. It is possible, 
however, that the relatively shorter length of data (3-4 min) used to estimate the transfer 
functions by Schondorf et al (19), might have lead to a higher variance which could have masked 
differences between the two groups. Schondorf et al (19) identified and discussed this issue in 
their paper. However, their results show (Figure 4 in reference (19)) that the differences in the 
dynamic CA coherence in the 0.2 to 0.5 Hz frequency region estimated using data which were 3 
to 4 minutes long and those that were 13 to 6 minutes long, were comparable to the differences 
in integrated coherencies seen by us between the two groups (Figure 20). On the other hand, any 
reduction in ability to detect differences in their study due to increased variance of estimate was 
possibly offset by the increased number of Presyncopal subjects that they had in their study. 
Therefore, it is not entirely clear why the observations of Schondorf et al’s study are inconsistent 
with those from our and Zhang et al’s study, a possibility remains, however, that technical 
aspects of cross spectral estimation may have contributed. 
  
Carey et al (5), suggested that although the reason behind the altered dynamic response remains 
unclear, a possible cause may be mean pressure in the middle cerebral artery falling outside the 
autoregulatory range. Results in Table 1 and Table 2, show that during Tilt Control, Presyncopal 
subjects had significantly lower values of MBP and SBP than Non-Presyncopal subjects. These 
results are consistent with the possibility proposed by Carey et al (5). Sung et al 2000 (23), 
suggested that it is possible that hyperventilation might lower the arterial CO2 levels and cause 
cerebral arteriolar constriction leading to syncope.  Comparing between the two groups, during 
Tilt Control, we observed a significant higher tidal volume (Table 1) in Presyncopal subjects and 
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a concurrent, but non significantly lower ETCO2. Whether the decrease in ETCO2 translated into 
similar levels of decrease in arterial CO2 is unclear, however, these results are consistent with the 
working hypothesis that cardio-respiratory interaction may play a contributing role in the genesis 
of orthostatically mediated syncope.  
 
One of the limitations of our study is relating changes in CBF and BP when the pressure at the 
level of middle cerebral artery is unknown.  As it is not possible to measure pressure at the level 
of middle cerebral artery, we as well as others use BP as a surrogate for perfusion pressure. The 
possibility remains that relating changes in these surrogates might fail to reflect what truly 
happens to the cerebral perfusion pressure and blood flow. 
 
Traditionally the relationship between CBF and BP has been measured by comparing a stable 
change in flow with a stable change in pressure and this is referred to as the static method. The 
static method has been very valuable, but animal and human studies suggest that cerebral blood 
flow regulation is a dynamic process with temporal heterogeneity. Dynamic cerebral regulation 
in humans has not been studied primarily because of the limited technology for high temporal 
resolution and continuous measurement of cerebral blood flow non- invasively (30). 
 
Although TCD technology offers the temporal resolution necessary to study these dynamic 
changes, we realize that velocity is not necessarily equal to flow. Changes in the measure flow 
are proportional to the changes in mean velocity only if the diameter of the MCA remains 
constant. Angiographic studies (7, 10) and direct visualization of the MCA during surgery (9) 
have suggested that, during a variety of stimuli known to affect blood flow, the diameter of the 
MCA changes minimally (<3%). However, the small changes in MCA diameter are difficult to 
measure and may produce large changes in velocity. The assumption made in our study is that 
the changes in MCA diameter are minimal (30). However, we consider that this is a reasonable 
assumption, likely to be correct based on empirical observations of others as stated above. 
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